Developed by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat (ATL-962) is an experimental treatment for obesity....
Read moreLipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics....
Read moreHalaven is a non-taxane drug developed by Eisai Co. for the treatment of metastatic breast cancer. In March 2010, Eisai...
Read moreBrussels-based biopharmaceutical company Union Chimique Belge (UCB) broke ground for a new biotechnology pilot facility in Belgium in June 2010....
Read moreVivalis opened a new R&D facility in Saint-Herblain, Nantes, France on 28 June 2010. The facility, located adjacent to its...
Read moreRoche Mustahzarlari has completed the construction of their pharmaceutical facility at Gebze, close to Istanbul, Turkey. The new drugs manufacturing...
Read moreQuintiles, a US-based biopharmaceutical services company, inaugurated its new research facility in London on 8 March 2010. Known as the...
Read moreNovo Nordisk is upgrading the insulin production plant at its facility in Chartres, Eure-et-Loir region, France. The Danish company is...
Read moreIndia-based contract manufacturer Kemwell launched a new solid and semi-solid pharmaceutical manufacturing facility in Sweden on 18 May 2010. Located...
Read moreIn April 2001 Eli Lilly announced it was constructing a new biotech bulk manufacturing facility in Carolina, Puerto Rico. Construction...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.